Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 10, Pages -
Publisher
Rockefeller University Press
Online
2020-07-27
DOI
10.1084/jem.20200389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status
- (2019) Eugenie Du et al. LARYNGOSCOPE
- Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
- (2019) David A. Jones et al. EUROPEAN JOURNAL OF CANCER
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research
- (2018) Aimée R. Kreimer et al. CANCER
- Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies
- (2018) Jian-Hong Fang et al. Journal of Cancer Research and Therapeutics
- Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma
- (2018) Nicole V. Anayannis et al. PLoS One
- Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer
- (2018) Sri Krishna et al. CANCER RESEARCH
- Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- (2018) Hisham Mehanna et al. LANCET
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- Immunotherapy for head and neck cancer: the future of treatment?
- (2017) Xiujie Xie et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?
- (2017) Iain Morgan et al. Viruses-Basel
- Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma
- (2017) Tara J. Nulton et al. Oncotarget
- Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
- (2017) H. van Meir et al. OncoImmunology
- CD8 + T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer
- (2016) Liam Masterson et al. EUROPEAN JOURNAL OF CANCER
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
- (2015) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study
- (2015) Karen S. Anderson et al. ORAL ONCOLOGY
- Chemoradiotherapy-Induced Upregulation of PD-1 Antagonizes Immunity to HPV-Related Oropharyngeal Cancer
- (2014) F. Parikh et al. CANCER RESEARCH
- De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials
- (2014) Liam Masterson et al. EUROPEAN JOURNAL OF CANCER
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
- (2013) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal Cancer
- (2010) Derrick Wansom et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus–Related Head and Neck Cancer
- (2009) William C. Spanos et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started